Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LBS-007 by Lin Bioscience for Myelodysplastic Syndrome: Likelihood of Approval
LBS-007 is under clinical development by Lin Bioscience and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase...
LBS-007 by Lin Bioscience for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia): Likelihood of Approval
LBS-007 is under clinical development by Lin Bioscience and currently in Phase II for Chronic Myelocytic Leukemia (CML, Chronic Myeloid...
LBS-007 by Lin Bioscience for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia): Likelihood of Approval
LBS-007 is under clinical development by Lin Bioscience and currently in Phase II for Chronic Myelocytic Leukemia (CML, Chronic Myeloid...
LBS-007 by Lin Bioscience for Myelodysplastic Syndrome: Likelihood of Approval
LBS-007 is under clinical development by Lin Bioscience and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase...